Company Intelligence

WhiteLab Genomics

WhiteLab Genomics provides enterprise-grade artificial intelligence solutions, delivering specialized Unleashing the potential of DNA and RNA based therapies using AI technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.

Headquarters
Paris, United States
Founded
2022
Employees
40
Stage
Growth
Status
Active
Products
1
Reports
8
Last reviewed
Aug 2026
AI in Healthcare Growth Active

Overview

What this company is, what it builds, and who it serves.

WhiteLab Genomics is a Healthcare AI company based in Paris, United States, founded in 2022.

WhiteLab Genomics develops unleashing the potential of DNA and RNA based therapies using AI.

What it does

Through the deployment of Unleashing the potential of DNA and RNA based therapies using AI, WhiteLab Genomics provides computational automation and data intelligence for organizations operating in Artificial Intelligence.

What it builds

Unleashing the potential of DNA and RNA based therapies using AI

Why It Matters

WhiteLab Genomics provides enterprise-grade artificial intelligence solutions, delivering specialized Unleashing the potential of DNA and RNA based therapies using AI technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.

Products

Products and platforms connected to this company.

Ecosystem

How this company connects across the Brel AI intelligence graph.

Company

WhiteLab Genomics

Industry

Capabilities

  • Unleashing the potential of DNA and RNA based therapies using AI

Features

  • Unleashing the potential of DNA and RNA based therapies using AI

Country

United States

Related companies

Official Resources

Official and developer links on file for this company.

Frequently Asked Questions

What does WhiteLab Genomics do?

WhiteLab Genomics specializes in artificial intelligence, developing Unleashing the potential of DNA and RNA based therapies using AI to support enterprise software developers and digital transformation teams with scalable, production-grade technology.

Where is WhiteLab Genomics based and when was it founded?

WhiteLab Genomics is based in United States and was founded in 2022.

What are the main products offered by WhiteLab Genomics?

The flagship platform from WhiteLab Genomics is Unleashing the potential of DNA and RNA based therapies using AI, delivered primarily through b2b saas and enterprise api licensing.

Who are the primary target users of WhiteLab Genomics?

WhiteLab Genomics primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.

Sources & Verification

How this profile is verified and where the information comes from.

Verified
Last reviewed Aug 2026

Primary sources

Request a correction if you represent this company or believe information is inaccurate.